Ulcer Recurrence Following First Ray Amputation in Diabetic Patients

A cohort prospective study

  1. Luca Dalla Paola, MD1,
  2. Ezio Faglia, MD2,
  3. Maurizio Caminiti, MD2,
  4. Giacomo Clerici, MD2,
  5. Sasa Ninkovic, MD1 and
  6. Valter Deanesi, MD3
  1. 1Diabetic Foot Unit, Presidio Ospedaliero Abano Terme, Padova, Italy
  2. 2Department of Internal Medicine, Policlinico Multimedica Sesto San Giovanni, Milano, Italy
  3. 3Department of Foot and Ankle Surgery, Casa di Cura “Villa Berioa,” Vicennza, Italy

    Abstract

    OBJECTIVE—to evaluate the reulceration and reamputation rates in a cohort of diabetic patients following first ray amputation.

    RESEARCH DESIGN AND METHODS—We evaluated a cohort of 89 diabetic patients, 63 men and 26 women, who underwent first ray amputation in the period from January 2000 to December 2001. The first ray lesions were Wagner grade 2 in 3 patients, Wagner grade 3 in 47 patients, and Wagner grade 4 in 39 patients. Following surgical wound healing, all patients wore special footwear with rocker bottom soles and custom molded insoles and were put on an intensive secondary prevention program.

    RESULTS—The mean follow-up duration was 16.35 ± 6.76 months (range 7–28). Fifteen patients developed new ulcerations, with 11 lesions occurring ipsilaterally and 4 contralaterally to the first ray amputation. In seven patients, the new lesion was treated and healed with dressing. Eight patients underwent a new surgical procedure: panmetatarsal head resection in four patients, toe amputation in two patients, a transmetatarsal amputation in one patient, and Lisfranc’s amputation in one patient.

    CONCLUSIONS—In the population studied, the first ray amputation presented a lower reulceration and reamputation rate with respect to that reported in the literature. This finding should therefore be attributed to the follow-up program, which uses shoes with a rocker bottom sole and custom molded insoles and intensive ambulatory check-ups.

    Footnotes

    • Address correspondence and reprint requests to Luca Dalla Paola, MD, Diabetic Foot Unit, Presidio Ospedaliero Abano Terme-ULSS 16 Padova, Piazza Cristoforo Colombo 1, 35031 Abano Terme (PD), Italy. E-mail: ldallapaola{at}libero.it.

      Received for publication 2 September 2002 and accepted in revised form 22 February 2003.

      A table elsewhere in this issue shows conventional and Système International (SI) units and conversion factors for many substances.

    « Previous | Next Article »Table of Contents